Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. Sasaki T, Watanabe J, He X, Katagi H, et al. J Neurosurg 2022 Nov 11:1-10. doi: 10.3171/2022.9.JNS22715.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sasaki T, Watanabe J, He X, Katagi H, et al. Intranasal delivery of nanoliposomal SN-38 for treatment of diffuse midline glioma. J Neurosurg 2022 Nov 11:1-10. doi: 10.3171/2022.9.JNS22715.
PMID: 36599085